Michael P Barker

Array ( [id] => 11348979 [patent_doc_number] => 20160367719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'FRACTIONS OF EXTRACTS OF HELICHRYSUM HAVING MUCOHADHESIVE PROPERTIES' [patent_app_type] => utility [patent_app_number] => 15/121248 [patent_app_country] => US [patent_app_date] => 2015-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11502 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15121248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11324890 [patent_doc_number] => 20160355502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'CATHEPSIN CYSTEINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/116518 [patent_app_country] => US [patent_app_date] => 2015-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41595 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15116518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11382861 [patent_doc_number] => 20170008917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'METHOD FOR PREPARING RACEMIC OR OPTICALLY ACTIVE alpha-GLYCEROPHOSPHORYLCHOLINE' [patent_app_type] => utility [patent_app_number] => 15/116302 [patent_app_country] => US [patent_app_date] => 2015-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5200 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15116302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10039229 [patent_doc_number] => 09079927 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-07-14 [patent_title] => 'Substituted imidazolium compounds for treating disease' [patent_app_type] => utility [patent_app_number] => 14/608855 [patent_app_country] => US [patent_app_date] => 2015-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5127 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14608855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10263349 [patent_doc_number] => 20150148346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'COMPOSITIONS OF 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS AND METHODS FOR THEIR USE' [patent_app_type] => utility [patent_app_number] => 14/607132 [patent_app_country] => US [patent_app_date] => 2015-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25851 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14607132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10548388 [patent_doc_number] => 09272998 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-03-01 [patent_title] => 'Modulation of c-FOS and BDNF protein expression in pentylenetetrazole-kindled mice following the treatment with novel anti-epileptic compound HHL-6' [patent_app_type] => utility [patent_app_number] => 14/607880 [patent_app_country] => US [patent_app_date] => 2015-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 3895 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14607880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12125072 [patent_doc_number] => 20180008658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'METHOD FOR PRODUCING A COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES EXHIBITING HYPOGLYCEMIC ACTIVITY' [patent_app_type] => utility [patent_app_number] => 15/543577 [patent_app_country] => US [patent_app_date] => 2015-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2252 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11471202 [patent_doc_number] => 20170057985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOBISPHOSPHITES' [patent_app_type] => utility [patent_app_number] => 15/117894 [patent_app_country] => US [patent_app_date] => 2015-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11549 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15117894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15481137 [patent_doc_number] => 10555894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-11 [patent_title] => Plant extract comprising sucrose esters as an active agent for use in cosmetic, dermatological or nutricosmetic composition [patent_app_type] => utility [patent_app_number] => 15/110215 [patent_app_country] => US [patent_app_date] => 2015-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 17360 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10283359 [patent_doc_number] => 20150168357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'METHOD OF EVALUATING PHARMACEUTICAL PREPARATION CONTAINING LULICONAZOLE AND INDEX SUBSTANCE' [patent_app_type] => utility [patent_app_number] => 14/592695 [patent_app_country] => US [patent_app_date] => 2015-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5900 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14592695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10305375 [patent_doc_number] => 20150190375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-09 [patent_title] => 'METHODS AND COMPOSITIONS INVOLVING (S)-BUCINDOLOL' [patent_app_type] => utility [patent_app_number] => 14/590661 [patent_app_country] => US [patent_app_date] => 2015-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18050 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14590661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11582830 [patent_doc_number] => 09637455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-02 [patent_title] => 'Heterocyclic sulfone RORγ modulators' [patent_app_type] => utility [patent_app_number] => 15/109727 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18529 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11225508 [patent_doc_number] => 09453222 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Ligand-conjugated monomers' [patent_app_type] => utility [patent_app_number] => 14/582284 [patent_app_country] => US [patent_app_date] => 2014-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 59518 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14582284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10294953 [patent_doc_number] => 20150179952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/576779 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4654 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14576779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11121926 [patent_doc_number] => 20160318900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => '2-AMINO-3-ESTER-PYRIDYL OREXIN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 15/105815 [patent_app_country] => US [patent_app_date] => 2014-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14525 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11121953 [patent_doc_number] => 20160318927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS' [patent_app_type] => utility [patent_app_number] => 15/105526 [patent_app_country] => US [patent_app_date] => 2014-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 60618 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11548414 [patent_doc_number] => 09617246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-11 [patent_title] => 'Thioether-piperidinyl orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 15/105808 [patent_app_country] => US [patent_app_date] => 2014-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16299 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11844533 [patent_doc_number] => 09732077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-15 [patent_title] => 'Diazepane orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 15/105825 [patent_app_country] => US [patent_app_date] => 2014-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14873 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11237437 [patent_doc_number] => 09464072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-11 [patent_title] => 'Treatment of central nervous system disorders' [patent_app_type] => utility [patent_app_number] => 14/569203 [patent_app_country] => US [patent_app_date] => 2014-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 18913 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14569203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12037572 [patent_doc_number] => 09815791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-14 [patent_title] => 'Alkylpyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 15/101129 [patent_app_country] => US [patent_app_date] => 2014-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16658 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15101129 [rel_patent_id] =>[rel_patent_doc_number] =>)